
|Articles|January 23, 2018
What Should Specialty Pharmacists Know About the ReDOS Clinical Trial?
Tanios Bekaii-Saab, MD, FACP, Mayo Clinic Cancer Center, talks about key takeaways from the phase 2 ReDOS clinical trial for specialty pharmacists.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ACIP Votes to End Universal Hepatitis B Vaccination Recommendation for Infants
2
MRD, ctDNA Testing May Help Diagnose Multiple Myeloma Precursor Conditions
3
American Cancer Society Updates Cervical Cancer Screening Guidelines to Include Self-Collection for HPV Testing
4
Low-Dose Cannabinoids Show Potential to Restore Serotonin Levels and Reduce Inflammation in HIV, Study Finds
5



















































































































































































































